Latest News
Antiparasitic Compound Could Hold Promise as Cholangiocarcinoma Treatment
ACYP1 Expression Linked With Worse Outcomes in Hepatic Carcinomas
Carbohydrate Antigen 19-9 Biomarker Shown Useful for Distal CCA Prognosis
Radiobiological Parameters Could Help Improve Treatment Outcomes in CCA
Study Suggests Tan-IIA Could Help Treat Cholangiocarcinoma
Potential New Biomarker for Extrahepatic Cholangiocarcinoma Identified
Bibliometric Machine Learning Reveals Rapid Increase in CCA Research
New Preoperative Model Predicts Overall Survival Among iCC Patients
Clinical Trial Reports Benefit of Ivosidenib in Cholangiocarcinoma
Latest Clinical Trials
Features
Cholangiocarcinoma Foundation Helps Improve Odds for Patients With Rare Bile Duct Cancer
Melinda Bachini, 52, never intended to be a patient advocate for a disease few people have ever heard of, let alone pronounce. But a Dec. 1, 2009, diagnosis of cholangiocarcinoma, also known as bile duct cancer, changed everything for the Billings, Montana, mother of 6. That day, the 41-year-old paramedic — who had been experiencing…
Israel Emerges as Global Powerhouse in Rare Disease Research
TEL AVIV, Israel — On the 6th floor of Schneider Children’s Hospital in the Tel Aviv suburb of Petah Tikva, 30 children with Alagille syndrome and 2 with lysosomal acid lipase deficiency (LAL-D) receive specialized treatment from a trio of pediatric hepatologists. Across town, at Sheba Medical Center’s Edmond and Lily Safra Children’s Hospital, pediatric…
NORD Recognizes Progress in Fight Against Rare Disease With 2021 Rare Impact Awards
Under COVID-19’s lingering shadow, the National Organization of Rare Disorders (NORD) has presented its 2021 Rare Impact Awards to 24 pharmaceutical firms, researchers, politicians, and nonprofit groups for their efforts over the past year on behalf of patients with such illnesses. The virtual ceremony was hosted by John Whyte, MD, MPH, chief medical officer at WebMD, with commentary…
FDA, CDC Urge COVID-19 Vaccines for Rare Disease Patients on NORD Webinar
As the super-contagious Delta variant of COVID-19 sweeps across the globe, driving up infection rates as well as deaths, top US health officials are urging everyone 12 and older — including the country’s 30 million or so rare disease patients — to get vaccinated quickly. Some 185 million people have been infected, and nearly 4…
Cholangiocarcinoma Clinical Insights
Artificial Intelligence Can Aid in Cholangiocarcinoma Diagnosis and Management
Artificial intelligence can play a role in identifying risk factors for cholangiocarcinoma, as well as in diagnosing and grading the disease.
Exploring Noninvasive Imaging in Intrahepatic Cholangiocarcinoma
Various imaging modalities can be used to diagnose and characterize intrahepatic cholangiocarcinoma and assess prognosis and treatment response.
The Challenges of Lymphadenectomy in Intrahepatic Cholangiocarcinoma
Cholangiocarcinoma is classified according to its occurrence along the biliary tree. For patients with intrahepatic cholangiocarcinoma, surgical resection is the only curative option. However, even post-surgery, intrahepatic cholangiocarcinoma is still associated with a high recurrence rate and poor survival. Lymph node metastasis is one of the most significant prognostic indicators post-surgery. However, detecting lymph node…
Mounting Evidence Supports Chemotherapy for Treatment of Biliary Tract Cancer
An increasing number of clinical studies have confirmed the utility of chemotherapy in treating malignancies of the biliary tract.
- Loading...
Loading...
Loading... 
Loading...